nodes	percent_of_prediction	percent_of_DWPC	metapath
Testosterone Propionate—CYP17A1—ovarian follicle—ovarian cancer	0.109	0.338	CbGeAlD
Testosterone Propionate—AR—oviduct—ovarian cancer	0.0257	0.0796	CbGeAlD
Testosterone Propionate—COMT—myometrium—ovarian cancer	0.0112	0.0348	CbGeAlD
Testosterone Propionate—CYP17A1—gonad—ovarian cancer	0.01	0.0311	CbGeAlD
Testosterone Propionate—AR—Regulation of Androgen receptor activity—SPDEF—ovarian cancer	0.00917	0.0576	CbGpPWpGaD
Testosterone Propionate—CYP17A1—female reproductive system—ovarian cancer	0.00896	0.0277	CbGeAlD
Testosterone Propionate—COMT—uterine cervix—ovarian cancer	0.00875	0.0271	CbGeAlD
Testosterone Propionate—COMT—decidua—ovarian cancer	0.00833	0.0258	CbGeAlD
Testosterone Propionate—AR—myometrium—ovarian cancer	0.00823	0.0255	CbGeAlD
Testosterone Propionate—CYP17A1—female gonad—ovarian cancer	0.00816	0.0252	CbGeAlD
Testosterone Propionate—COMT—endometrium—ovarian cancer	0.00791	0.0245	CbGeAlD
Testosterone Propionate—COMT—gonad—ovarian cancer	0.00734	0.0227	CbGeAlD
Testosterone Propionate—COMT—uterus—ovarian cancer	0.00729	0.0226	CbGeAlD
Testosterone Propionate—COMT—Dopamine metabolism—SOD1—ovarian cancer	0.00725	0.0456	CbGpPWpGaD
Testosterone Propionate—CYP17A1—testis—ovarian cancer	0.00723	0.0224	CbGeAlD
Testosterone Propionate—COMT—female reproductive system—ovarian cancer	0.00655	0.0203	CbGeAlD
Testosterone Propionate—AR—epithelium—ovarian cancer	0.00646	0.02	CbGeAlD
Testosterone Propionate—AR—uterine cervix—ovarian cancer	0.0064	0.0198	CbGeAlD
Testosterone Propionate—COMT—Estrogen metabolism—CYP1B1—ovarian cancer	0.00627	0.0394	CbGpPWpGaD
Testosterone Propionate—COMT—bone marrow—ovarian cancer	0.00619	0.0191	CbGeAlD
Testosterone Propionate—AR—decidua—ovarian cancer	0.0061	0.0189	CbGeAlD
Testosterone Propionate—COMT—female gonad—ovarian cancer	0.00596	0.0185	CbGeAlD
Testosterone Propionate—COMT—vagina—ovarian cancer	0.00593	0.0183	CbGeAlD
Testosterone Propionate—UGT1A1—Codeine and Morphine Metabolism—ABCB1—ovarian cancer	0.00592	0.0372	CbGpPWpGaD
Testosterone Propionate—AR—endometrium—ovarian cancer	0.00579	0.0179	CbGeAlD
Testosterone Propionate—AR—Nuclear Receptors—NR5A1—ovarian cancer	0.00549	0.0345	CbGpPWpGaD
Testosterone Propionate—AR—gonad—ovarian cancer	0.00537	0.0166	CbGeAlD
Testosterone Propionate—AR—uterus—ovarian cancer	0.00534	0.0165	CbGeAlD
Testosterone Propionate—COMT—testis—ovarian cancer	0.00529	0.0164	CbGeAlD
Testosterone Propionate—CYP17A1—lymph node—ovarian cancer	0.00524	0.0162	CbGeAlD
Testosterone Propionate—CYP17A1—Endogenous sterols—CYP1B1—ovarian cancer	0.00494	0.031	CbGpPWpGaD
Testosterone Propionate—AR—female reproductive system—ovarian cancer	0.0048	0.0148	CbGeAlD
Testosterone Propionate—AR—female gonad—ovarian cancer	0.00436	0.0135	CbGeAlD
Testosterone Propionate—AR—Nuclear Receptor transcription pathway—NR5A1—ovarian cancer	0.00434	0.0273	CbGpPWpGaD
Testosterone Propionate—AR—vagina—ovarian cancer	0.00434	0.0134	CbGeAlD
Testosterone Propionate—AR—testis—ovarian cancer	0.00387	0.012	CbGeAlD
Testosterone Propionate—COMT—lymph node—ovarian cancer	0.00383	0.0119	CbGeAlD
Testosterone Propionate—UGT1A1—Estrogen metabolism—CYP1B1—ovarian cancer	0.00376	0.0236	CbGpPWpGaD
Testosterone Propionate—Dydrogesterone—PGR—ovarian cancer	0.0037	0.115	CrCbGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—BCL9—ovarian cancer	0.00346	0.0218	CbGpPWpGaD
Testosterone Propionate—Ethynodiol—PGR—ovarian cancer	0.00305	0.0944	CrCbGaD
Testosterone Propionate—AR—lymph node—ovarian cancer	0.00281	0.00868	CbGeAlD
Testosterone Propionate—AR—Nuclear Receptors—PGR—ovarian cancer	0.00274	0.0172	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Irinotecan Pathway—APC—ovarian cancer	0.00273	0.0171	CbGpPWpGaD
Testosterone Propionate—Norgestimate—PGR—ovarian cancer	0.00259	0.0802	CrCbGaD
Testosterone Propionate—CYP17A1—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.00229	0.0144	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.00226	0.0142	CbGpPWpGaD
Testosterone Propionate—Megestrol acetate—PGR—ovarian cancer	0.00223	0.0689	CrCbGaD
Testosterone Propionate—AR—Nuclear Receptor transcription pathway—PGR—ovarian cancer	0.00216	0.0136	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—NSF—ovarian cancer	0.00216	0.0136	CbGpPWpGaD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—PARP1—ovarian cancer	0.00215	0.0135	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.00195	0.0123	CbGpPWpGaD
Testosterone Propionate—AR—FOXA1 transcription factor network—BRCA1—ovarian cancer	0.00195	0.0122	CbGpPWpGaD
Testosterone Propionate—Drospirenone—PGR—ovarian cancer	0.00194	0.0602	CrCbGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—BARD1—ovarian cancer	0.00194	0.0122	CbGpPWpGaD
Testosterone Propionate—Ethynodiol—ESR1—ovarian cancer	0.00192	0.0596	CrCbGaD
Testosterone Propionate—CYP17A1—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.00186	0.0117	CbGpPWpGaD
Testosterone Propionate—AR—FOXA1 transcription factor network—SOD1—ovarian cancer	0.00184	0.0116	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CD82—ovarian cancer	0.0018	0.0113	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CYP1B1—ovarian cancer	0.00177	0.0111	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—ATF3—ovarian cancer	0.00173	0.0109	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—NSF—ovarian cancer	0.00165	0.0104	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—SMARCA4—ovarian cancer	0.00165	0.0104	CbGpPWpGaD
Testosterone Propionate—Norgestimate—ESR1—ovarian cancer	0.00164	0.0507	CrCbGaD
Testosterone Propionate—Levonorgestrel—PGR—ovarian cancer	0.00159	0.0491	CrCbGaD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—BRCA1—ovarian cancer	0.0015	0.00941	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TOP1—ovarian cancer	0.00147	0.00922	CbGpPWpGaD
Testosterone Propionate—AR—Nuclear Receptors—ESR1—ovarian cancer	0.00146	0.00918	CbGpPWpGaD
Testosterone Propionate—Danazol—PGR—ovarian cancer	0.00144	0.0447	CrCbGaD
Testosterone Propionate—Spironolactone—PGR—ovarian cancer	0.00138	0.0429	CrCbGaD
Testosterone Propionate—Pain—Melphalan—ovarian cancer	0.00134	0.00277	CcSEcCtD
Testosterone Propionate—Neoplasm—Epirubicin—ovarian cancer	0.00134	0.00275	CcSEcCtD
Testosterone Propionate—Skin disorder—Vinorelbine—ovarian cancer	0.00133	0.00275	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Chlorambucil—ovarian cancer	0.00133	0.00273	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Topotecan—ovarian cancer	0.00132	0.00272	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Topotecan—ovarian cancer	0.00131	0.0027	CcSEcCtD
Testosterone Propionate—Haemoglobin—Paclitaxel—ovarian cancer	0.00131	0.00269	CcSEcCtD
Testosterone Propionate—AR—FOXA1 transcription factor network—ESR1—ovarian cancer	0.0013	0.00816	CbGpPWpGaD
Testosterone Propionate—Haemorrhage—Paclitaxel—ovarian cancer	0.0013	0.00268	CcSEcCtD
Testosterone Propionate—Medroxyprogesterone Acetate—PGR—ovarian cancer	0.0013	0.0402	CrCbGaD
Testosterone Propionate—Asthenia—Chlorambucil—ovarian cancer	0.00129	0.00266	CcSEcCtD
Testosterone Propionate—Norethindrone—PGR—ovarian cancer	0.00128	0.0398	CrCbGaD
Testosterone Propionate—Urinary tract disorder—Paclitaxel—ovarian cancer	0.00128	0.00264	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Paclitaxel—ovarian cancer	0.00128	0.00263	CcSEcCtD
Testosterone Propionate—Pruritus—Chlorambucil—ovarian cancer	0.00127	0.00263	CcSEcCtD
Testosterone Propionate—Urticaria—Topotecan—ovarian cancer	0.00127	0.00262	CcSEcCtD
Testosterone Propionate—Urethral disorder—Paclitaxel—ovarian cancer	0.00127	0.00262	CcSEcCtD
Testosterone Propionate—Abdominal pain—Topotecan—ovarian cancer	0.00127	0.00261	CcSEcCtD
Testosterone Propionate—Weight increased—Docetaxel—ovarian cancer	0.00125	0.00258	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.00125	0.00258	CcSEcCtD
Testosterone Propionate—Urticaria—Melphalan—ovarian cancer	0.00125	0.00257	CcSEcCtD
Testosterone Propionate—Neoplasm—Doxorubicin—ovarian cancer	0.00124	0.00255	CcSEcCtD
Testosterone Propionate—Diarrhoea—Chlorambucil—ovarian cancer	0.00123	0.00254	CcSEcCtD
Testosterone Propionate—Paraesthesia—Vinorelbine—ovarian cancer	0.00123	0.00254	CcSEcCtD
Testosterone Propionate—Dyspnoea—Vinorelbine—ovarian cancer	0.00122	0.00252	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND2—ovarian cancer	0.00121	0.00757	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00118	0.00244	CcSEcCtD
Testosterone Propionate—Fatigue—Vinorelbine—ovarian cancer	0.00118	0.00244	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Topotecan—ovarian cancer	0.00118	0.00243	CcSEcCtD
Testosterone Propionate—Angiopathy—Paclitaxel—ovarian cancer	0.00118	0.00243	CcSEcCtD
Testosterone Propionate—Pain—Vinorelbine—ovarian cancer	0.00117	0.00242	CcSEcCtD
Testosterone Propionate—Immune system disorder—Paclitaxel—ovarian cancer	0.00117	0.00242	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Paclitaxel—ovarian cancer	0.00117	0.00241	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Docetaxel—ovarian cancer	0.00116	0.00239	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Melphalan—ovarian cancer	0.00116	0.00238	CcSEcCtD
Testosterone Propionate—AR—Nuclear Receptor transcription pathway—ESR1—ovarian cancer	0.00115	0.00725	CbGpPWpGaD
Testosterone Propionate—Asthenia—Topotecan—ovarian cancer	0.00115	0.00237	CcSEcCtD
Testosterone Propionate—Alopecia—Paclitaxel—ovarian cancer	0.00115	0.00236	CcSEcCtD
Testosterone Propionate—Vomiting—Chlorambucil—ovarian cancer	0.00115	0.00236	CcSEcCtD
Testosterone Propionate—Increased appetite—Epirubicin—ovarian cancer	0.00114	0.00235	CcSEcCtD
Testosterone Propionate—Mental disorder—Paclitaxel—ovarian cancer	0.00114	0.00234	CcSEcCtD
Testosterone Propionate—Pruritus—Topotecan—ovarian cancer	0.00113	0.00234	CcSEcCtD
Testosterone Propionate—Malnutrition—Paclitaxel—ovarian cancer	0.00113	0.00233	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Vinorelbine—ovarian cancer	0.00113	0.00233	CcSEcCtD
Testosterone Propionate—Asthenia—Melphalan—ovarian cancer	0.00113	0.00232	CcSEcCtD
Testosterone Propionate—Dermatitis bullous—Epirubicin—ovarian cancer	0.00112	0.00231	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00112	0.00231	CcSEcCtD
Testosterone Propionate—Pruritus—Melphalan—ovarian cancer	0.00111	0.00229	CcSEcCtD
Testosterone Propionate—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.00111	0.00228	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—BRCA1—ovarian cancer	0.00111	0.00695	CbGpPWpGaD
Testosterone Propionate—Haemoglobin—Docetaxel—ovarian cancer	0.00111	0.00228	CcSEcCtD
Testosterone Propionate—Haemorrhage—Docetaxel—ovarian cancer	0.0011	0.00227	CcSEcCtD
Testosterone Propionate—Diarrhoea—Topotecan—ovarian cancer	0.0011	0.00226	CcSEcCtD
Testosterone Propionate—Urticaria—Vinorelbine—ovarian cancer	0.00109	0.00225	CcSEcCtD
Testosterone Propionate—Urinary tract disorder—Docetaxel—ovarian cancer	0.00109	0.00224	CcSEcCtD
Testosterone Propionate—Abdominal pain—Vinorelbine—ovarian cancer	0.00108	0.00223	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Docetaxel—ovarian cancer	0.00108	0.00223	CcSEcCtD
Testosterone Propionate—Urethral disorder—Docetaxel—ovarian cancer	0.00108	0.00222	CcSEcCtD
Testosterone Propionate—Diarrhoea—Melphalan—ovarian cancer	0.00107	0.00221	CcSEcCtD
Testosterone Propionate—Gastrointestinal haemorrhage—Epirubicin—ovarian cancer	0.00107	0.00221	CcSEcCtD
Testosterone Propionate—Nausea—Chlorambucil—ovarian cancer	0.00107	0.0022	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—MSH2—ovarian cancer	0.00106	0.00667	CbGpPWpGaD
Testosterone Propionate—Dizziness—Topotecan—ovarian cancer	0.00106	0.00218	CcSEcCtD
Testosterone Propionate—Increased appetite—Doxorubicin—ovarian cancer	0.00106	0.00218	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Paclitaxel—ovarian cancer	0.00105	0.00216	CcSEcCtD
Testosterone Propionate—Dermatitis bullous—Doxorubicin—ovarian cancer	0.00104	0.00214	CcSEcCtD
Testosterone Propionate—COMT—Biological oxidations—CYP1B1—ovarian cancer	0.00103	0.00648	CbGpPWpGaD
Testosterone Propionate—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.00103	0.00211	CcSEcCtD
Testosterone Propionate—Vomiting—Topotecan—ovarian cancer	0.00102	0.0021	CcSEcCtD
Testosterone Propionate—Malaise—Paclitaxel—ovarian cancer	0.00102	0.0021	CcSEcCtD
Testosterone Propionate—COMT—Metapathway biotransformation—CYP1B1—ovarian cancer	0.00102	0.00639	CbGpPWpGaD
Testosterone Propionate—Rash—Topotecan—ovarian cancer	0.00101	0.00208	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Vinorelbine—ovarian cancer	0.00101	0.00208	CcSEcCtD
Testosterone Propionate—Dermatitis—Topotecan—ovarian cancer	0.00101	0.00208	CcSEcCtD
Testosterone Propionate—Headache—Topotecan—ovarian cancer	0.001	0.00207	CcSEcCtD
Testosterone Propionate—Levonorgestrel—ESR1—ovarian cancer	0.001	0.031	CrCbGaD
Testosterone Propionate—Angiopathy—Docetaxel—ovarian cancer	0.000999	0.00206	CcSEcCtD
Testosterone Propionate—Vomiting—Melphalan—ovarian cancer	0.000998	0.00206	CcSEcCtD
Testosterone Propionate—Immune system disorder—Docetaxel—ovarian cancer	0.000994	0.00205	CcSEcCtD
Testosterone Propionate—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	0.000993	0.00205	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Docetaxel—ovarian cancer	0.000992	0.00204	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—SMARCA4—ovarian cancer	0.000992	0.00623	CbGpPWpGaD
Testosterone Propionate—Liver function test abnormal—Epirubicin—ovarian cancer	0.000991	0.00204	CcSEcCtD
Testosterone Propionate—Rash—Melphalan—ovarian cancer	0.00099	0.00204	CcSEcCtD
Testosterone Propionate—Dermatitis—Melphalan—ovarian cancer	0.000989	0.00204	CcSEcCtD
Testosterone Propionate—CYP17A1—Biological oxidations—CYP1B1—ovarian cancer	0.000987	0.0062	CbGpPWpGaD
Testosterone Propionate—Asthenia—Vinorelbine—ovarian cancer	0.000984	0.00203	CcSEcCtD
Testosterone Propionate—Hypertension—Paclitaxel—ovarian cancer	0.000976	0.00201	CcSEcCtD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000974	0.00612	CbGpPWpGaD
Testosterone Propionate—Alopecia—Docetaxel—ovarian cancer	0.000973	0.002	CcSEcCtD
Testosterone Propionate—Pruritus—Vinorelbine—ovarian cancer	0.00097	0.002	CcSEcCtD
Testosterone Propionate—Breast disorder—Epirubicin—ovarian cancer	0.00097	0.002	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—CCNE1—ovarian cancer	0.00097	0.00609	CbGpPWpGaD
Testosterone Propionate—Mental disorder—Docetaxel—ovarian cancer	0.000964	0.00199	CcSEcCtD
Testosterone Propionate—Myalgia—Paclitaxel—ovarian cancer	0.000962	0.00198	CcSEcCtD
Testosterone Propionate—Arthralgia—Paclitaxel—ovarian cancer	0.000962	0.00198	CcSEcCtD
Testosterone Propionate—Anxiety—Paclitaxel—ovarian cancer	0.000959	0.00198	CcSEcCtD
Testosterone Propionate—Malnutrition—Docetaxel—ovarian cancer	0.000958	0.00197	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000956	0.00197	CcSEcCtD
Testosterone Propionate—Fluoxymesterone—ESR1—ovarian cancer	0.000954	0.0296	CrCbGaD
Testosterone Propionate—Nausea—Topotecan—ovarian cancer	0.000952	0.00196	CcSEcCtD
Testosterone Propionate—Discomfort—Paclitaxel—ovarian cancer	0.000951	0.00196	CcSEcCtD
Testosterone Propionate—Diarrhoea—Vinorelbine—ovarian cancer	0.000939	0.00193	CcSEcCtD
Testosterone Propionate—Nausea—Melphalan—ovarian cancer	0.000933	0.00192	CcSEcCtD
Testosterone Propionate—Confusional state—Paclitaxel—ovarian cancer	0.00093	0.00192	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000923	0.0019	CcSEcCtD
Testosterone Propionate—Oedema—Paclitaxel—ovarian cancer	0.000923	0.0019	CcSEcCtD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—MAPK3—ovarian cancer	0.000919	0.00577	CbGpPWpGaD
Testosterone Propionate—Liver function test abnormal—Doxorubicin—ovarian cancer	0.000917	0.00189	CcSEcCtD
Testosterone Propionate—Danazol—ESR1—ovarian cancer	0.000912	0.0282	CrCbGaD
Testosterone Propionate—Dizziness—Vinorelbine—ovarian cancer	0.000907	0.00187	CcSEcCtD
Testosterone Propionate—Nervous system disorder—Paclitaxel—ovarian cancer	0.000905	0.00186	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—ovarian cancer	0.000903	0.00567	CbGpPWpGaD
Testosterone Propionate—Breast disorder—Doxorubicin—ovarian cancer	0.000897	0.00185	CcSEcCtD
Testosterone Propionate—Skin disorder—Paclitaxel—ovarian cancer	0.000896	0.00185	CcSEcCtD
Testosterone Propionate—AR—FOXA1 transcription factor network—CDKN1B—ovarian cancer	0.000883	0.00555	CbGpPWpGaD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—MAPK1—ovarian cancer	0.000875	0.00549	CbGpPWpGaD
Testosterone Propionate—Vomiting—Vinorelbine—ovarian cancer	0.000872	0.0018	CcSEcCtD
Testosterone Propionate—Dysuria—Epirubicin—ovarian cancer	0.000867	0.00179	CcSEcCtD
Testosterone Propionate—Rash—Vinorelbine—ovarian cancer	0.000865	0.00178	CcSEcCtD
Testosterone Propionate—Dermatitis—Vinorelbine—ovarian cancer	0.000864	0.00178	CcSEcCtD
Testosterone Propionate—Headache—Vinorelbine—ovarian cancer	0.000859	0.00177	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—GADD45A—ovarian cancer	0.000847	0.00532	CbGpPWpGaD
Testosterone Propionate—Weight increased—Epirubicin—ovarian cancer	0.000844	0.00174	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000841	0.00173	CcSEcCtD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—CDKN1B—ovarian cancer	0.000838	0.00526	CbGpPWpGaD
Testosterone Propionate—Insomnia—Paclitaxel—ovarian cancer	0.000834	0.00172	CcSEcCtD
Testosterone Propionate—Paraesthesia—Paclitaxel—ovarian cancer	0.000828	0.00171	CcSEcCtD
Testosterone Propionate—Hypertension—Docetaxel—ovarian cancer	0.000827	0.0017	CcSEcCtD
Testosterone Propionate—Dyspnoea—Paclitaxel—ovarian cancer	0.000823	0.00169	CcSEcCtD
Testosterone Propionate—Medroxyprogesterone Acetate—ESR1—ovarian cancer	0.000818	0.0254	CrCbGaD
Testosterone Propionate—Arthralgia—Docetaxel—ovarian cancer	0.000816	0.00168	CcSEcCtD
Testosterone Propionate—Myalgia—Docetaxel—ovarian cancer	0.000816	0.00168	CcSEcCtD
Testosterone Propionate—Nausea—Vinorelbine—ovarian cancer	0.000815	0.00168	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00081	0.00167	CcSEcCtD
Testosterone Propionate—Dysuria—Doxorubicin—ovarian cancer	0.000803	0.00165	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—ovarian cancer	0.000797	0.00501	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000797	0.00164	CcSEcCtD
Testosterone Propionate—Fatigue—Paclitaxel—ovarian cancer	0.000795	0.00164	CcSEcCtD
Testosterone Propionate—Pain—Paclitaxel—ovarian cancer	0.000789	0.00163	CcSEcCtD
Testosterone Propionate—Haematuria—Epirubicin—ovarian cancer	0.000789	0.00162	CcSEcCtD
Testosterone Propionate—Confusional state—Docetaxel—ovarian cancer	0.000789	0.00162	CcSEcCtD
Testosterone Propionate—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000782	0.00161	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Docetaxel—ovarian cancer	0.000782	0.00161	CcSEcCtD
Testosterone Propionate—Oedema—Docetaxel—ovarian cancer	0.000782	0.00161	CcSEcCtD
Testosterone Propionate—Weight increased—Doxorubicin—ovarian cancer	0.000781	0.00161	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CHEK2—ovarian cancer	0.000774	0.00486	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—CAV1—ovarian cancer	0.000767	0.00482	CbGpPWpGaD
Testosterone Propionate—Nervous system disorder—Docetaxel—ovarian cancer	0.000767	0.00158	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000761	0.00478	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—ovarian cancer	0.000761	0.00478	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—SLC5A5—ovarian cancer	0.00076	0.00478	CbGpPWpGaD
Testosterone Propionate—Feeling abnormal—Paclitaxel—ovarian cancer	0.00076	0.00157	CcSEcCtD
Testosterone Propionate—Skin disorder—Docetaxel—ovarian cancer	0.00076	0.00157	CcSEcCtD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—PIK3CA—ovarian cancer	0.000759	0.00477	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	0.000757	0.00476	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000754	0.00155	CcSEcCtD
Testosterone Propionate—AR—Generic Transcription Pathway—NR5A1—ovarian cancer	0.00075	0.00471	CbGpPWpGaD
Testosterone Propionate—Progesterone—PGR—ovarian cancer	0.000749	0.0232	CrCbGaD
Testosterone Propionate—Haemoglobin—Epirubicin—ovarian cancer	0.000746	0.00154	CcSEcCtD
Testosterone Propionate—Haemorrhage—Epirubicin—ovarian cancer	0.000742	0.00153	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	0.000741	0.00465	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—SLC2A1—ovarian cancer	0.000734	0.00461	CbGpPWpGaD
Testosterone Propionate—Urinary tract disorder—Epirubicin—ovarian cancer	0.000733	0.00151	CcSEcCtD
Testosterone Propionate—Urticaria—Paclitaxel—ovarian cancer	0.000733	0.00151	CcSEcCtD
Testosterone Propionate—Haematuria—Doxorubicin—ovarian cancer	0.00073	0.0015	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Epirubicin—ovarian cancer	0.00073	0.0015	CcSEcCtD
Testosterone Propionate—Abdominal pain—Paclitaxel—ovarian cancer	0.000729	0.0015	CcSEcCtD
Testosterone Propionate—Urethral disorder—Epirubicin—ovarian cancer	0.000728	0.0015	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—BRCA1—ovarian cancer	0.000725	0.00456	CbGpPWpGaD
Testosterone Propionate—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000724	0.00149	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000712	0.00147	CcSEcCtD
Testosterone Propionate—Insomnia—Docetaxel—ovarian cancer	0.000707	0.00146	CcSEcCtD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—HRAS—ovarian cancer	0.000702	0.00441	CbGpPWpGaD
Testosterone Propionate—Paraesthesia—Docetaxel—ovarian cancer	0.000702	0.00145	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—GADD45A—ovarian cancer	0.000702	0.00441	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—ovarian cancer	0.000701	0.0044	CbGpPWpGaD
Testosterone Propionate—Progesterone—CYP1B1—ovarian cancer	0.0007	0.0217	CrCbGaD
Testosterone Propionate—Dyspnoea—Docetaxel—ovarian cancer	0.000697	0.00144	CcSEcCtD
Testosterone Propionate—Haemoglobin—Doxorubicin—ovarian cancer	0.00069	0.00142	CcSEcCtD
Testosterone Propionate—AR—Notch-mediated HES/HEY network—STAT3—ovarian cancer	0.00069	0.00433	CbGpPWpGaD
Testosterone Propionate—Haemorrhage—Doxorubicin—ovarian cancer	0.000687	0.00142	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Paclitaxel—ovarian cancer	0.00068	0.0014	CcSEcCtD
Testosterone Propionate—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000678	0.0014	CcSEcCtD
Testosterone Propionate—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000675	0.00139	CcSEcCtD
Testosterone Propionate—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000675	0.00139	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—ovarian cancer	0.000674	0.00424	CbGpPWpGaD
Testosterone Propionate—Fatigue—Docetaxel—ovarian cancer	0.000674	0.00139	CcSEcCtD
Testosterone Propionate—Angiopathy—Epirubicin—ovarian cancer	0.000674	0.00139	CcSEcCtD
Testosterone Propionate—Urethral disorder—Doxorubicin—ovarian cancer	0.000673	0.00139	CcSEcCtD
Testosterone Propionate—Immune system disorder—Epirubicin—ovarian cancer	0.000671	0.00138	CcSEcCtD
Testosterone Propionate—Mediastinal disorder—Epirubicin—ovarian cancer	0.000669	0.00138	CcSEcCtD
Testosterone Propionate—Pain—Docetaxel—ovarian cancer	0.000669	0.00138	CcSEcCtD
Testosterone Propionate—Asthenia—Paclitaxel—ovarian cancer	0.000662	0.00136	CcSEcCtD
Testosterone Propionate—Testosterone—CYP1B1—ovarian cancer	0.000661	0.0205	CrCbGaD
Testosterone Propionate—Alopecia—Epirubicin—ovarian cancer	0.000656	0.00135	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—BRCA2—ovarian cancer	0.000656	0.00412	CbGpPWpGaD
Testosterone Propionate—Pruritus—Paclitaxel—ovarian cancer	0.000653	0.00134	CcSEcCtD
Testosterone Propionate—Mental disorder—Epirubicin—ovarian cancer	0.00065	0.00134	CcSEcCtD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—CCND1—ovarian cancer	0.000649	0.00407	CbGpPWpGaD
Testosterone Propionate—Malnutrition—Epirubicin—ovarian cancer	0.000646	0.00133	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Docetaxel—ovarian cancer	0.000644	0.00133	CcSEcCtD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—CTNNB1—ovarian cancer	0.000642	0.00403	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	0.000641	0.00403	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000639	0.00132	CcSEcCtD
Testosterone Propionate—Diarrhoea—Paclitaxel—ovarian cancer	0.000631	0.0013	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—NME2—ovarian cancer	0.000629	0.00395	CbGpPWpGaD
Testosterone Propionate—Angiopathy—Doxorubicin—ovarian cancer	0.000623	0.00128	CcSEcCtD
Testosterone Propionate—Immune system disorder—Doxorubicin—ovarian cancer	0.000621	0.00128	CcSEcCtD
Testosterone Propionate—AR—Nongenotropic Androgen signaling—AKT1—ovarian cancer	0.00062	0.0039	CbGpPWpGaD
Testosterone Propionate—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000619	0.00128	CcSEcCtD
Testosterone Propionate—Abdominal pain—Docetaxel—ovarian cancer	0.000618	0.00127	CcSEcCtD
Testosterone Propionate—UGT1A1—Biological oxidations—CYP1B1—ovarian cancer	0.000618	0.00388	CbGpPWpGaD
Testosterone Propionate—Dizziness—Paclitaxel—ovarian cancer	0.00061	0.00126	CcSEcCtD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000609	0.00383	CbGpPWpGaD
Testosterone Propionate—Alopecia—Doxorubicin—ovarian cancer	0.000607	0.00125	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—NME2—ovarian cancer	0.000602	0.00378	CbGpPWpGaD
Testosterone Propionate—Mental disorder—Doxorubicin—ovarian cancer	0.000602	0.00124	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	0.000601	0.00377	CbGpPWpGaD
Testosterone Propionate—Ill-defined disorder—Epirubicin—ovarian cancer	0.0006	0.00124	CcSEcCtD
Testosterone Propionate—Malnutrition—Doxorubicin—ovarian cancer	0.000598	0.00123	CcSEcCtD
Testosterone Propionate—Megestrol acetate—ABCB1—ovarian cancer	0.000597	0.0185	CrCbGaD
Testosterone Propionate—Vomiting—Paclitaxel—ovarian cancer	0.000587	0.00121	CcSEcCtD
Testosterone Propionate—Malaise—Epirubicin—ovarian cancer	0.000583	0.0012	CcSEcCtD
Testosterone Propionate—Rash—Paclitaxel—ovarian cancer	0.000582	0.0012	CcSEcCtD
Testosterone Propionate—Dermatitis—Paclitaxel—ovarian cancer	0.000581	0.0012	CcSEcCtD
Testosterone Propionate—Headache—Paclitaxel—ovarian cancer	0.000578	0.00119	CcSEcCtD
Testosterone Propionate—Hypersensitivity—Docetaxel—ovarian cancer	0.000576	0.00119	CcSEcCtD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	0.000567	0.00356	CbGpPWpGaD
Testosterone Propionate—Asthenia—Docetaxel—ovarian cancer	0.000561	0.00116	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—ovarian cancer	0.00056	0.00352	CbGpPWpGaD
Testosterone Propionate—Hypertension—Epirubicin—ovarian cancer	0.000558	0.00115	CcSEcCtD
Testosterone Propionate—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000555	0.00114	CcSEcCtD
Testosterone Propionate—Pruritus—Docetaxel—ovarian cancer	0.000553	0.00114	CcSEcCtD
Testosterone Propionate—Myalgia—Epirubicin—ovarian cancer	0.00055	0.00113	CcSEcCtD
Testosterone Propionate—Arthralgia—Epirubicin—ovarian cancer	0.00055	0.00113	CcSEcCtD
Testosterone Propionate—Anxiety—Epirubicin—ovarian cancer	0.000548	0.00113	CcSEcCtD
Testosterone Propionate—Nausea—Paclitaxel—ovarian cancer	0.000548	0.00113	CcSEcCtD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000546	0.00113	CcSEcCtD
Testosterone Propionate—Discomfort—Epirubicin—ovarian cancer	0.000544	0.00112	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	0.000543	0.00341	CbGpPWpGaD
Testosterone Propionate—Malaise—Doxorubicin—ovarian cancer	0.000539	0.00111	CcSEcCtD
Testosterone Propionate—Diarrhoea—Docetaxel—ovarian cancer	0.000535	0.0011	CcSEcCtD
Testosterone Propionate—Confusional state—Epirubicin—ovarian cancer	0.000532	0.0011	CcSEcCtD
Testosterone Propionate—Oedema—Epirubicin—ovarian cancer	0.000527	0.00109	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Epirubicin—ovarian cancer	0.000527	0.00109	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	0.000526	0.00331	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	0.000526	0.00331	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—ovarian cancer	0.000522	0.00328	CbGpPWpGaD
Testosterone Propionate—Nervous system disorder—Epirubicin—ovarian cancer	0.000517	0.00107	CcSEcCtD
Testosterone Propionate—Dizziness—Docetaxel—ovarian cancer	0.000517	0.00107	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—ovarian cancer	0.000517	0.00325	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	0.000517	0.00325	CbGpPWpGaD
Testosterone Propionate—Hypertension—Doxorubicin—ovarian cancer	0.000516	0.00106	CcSEcCtD
Testosterone Propionate—Skin disorder—Epirubicin—ovarian cancer	0.000512	0.00106	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000511	0.00321	CbGpPWpGaD
Testosterone Propionate—Myalgia—Doxorubicin—ovarian cancer	0.000509	0.00105	CcSEcCtD
Testosterone Propionate—Arthralgia—Doxorubicin—ovarian cancer	0.000509	0.00105	CcSEcCtD
Testosterone Propionate—Anxiety—Doxorubicin—ovarian cancer	0.000507	0.00105	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—ovarian cancer	0.000507	0.00318	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—WDR77—ovarian cancer	0.000507	0.00318	CbGpPWpGaD
Testosterone Propionate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000506	0.00104	CcSEcCtD
Testosterone Propionate—Discomfort—Doxorubicin—ovarian cancer	0.000503	0.00104	CcSEcCtD
Testosterone Propionate—Vomiting—Docetaxel—ovarian cancer	0.000497	0.00102	CcSEcCtD
Testosterone Propionate—Rash—Docetaxel—ovarian cancer	0.000493	0.00102	CcSEcCtD
Testosterone Propionate—Dermatitis—Docetaxel—ovarian cancer	0.000493	0.00102	CcSEcCtD
Testosterone Propionate—Confusional state—Doxorubicin—ovarian cancer	0.000492	0.00101	CcSEcCtD
Testosterone Propionate—Headache—Docetaxel—ovarian cancer	0.00049	0.00101	CcSEcCtD
Testosterone Propionate—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000488	0.00101	CcSEcCtD
Testosterone Propionate—Oedema—Doxorubicin—ovarian cancer	0.000488	0.00101	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—ESR1—ovarian cancer	0.000484	0.00304	CbGpPWpGaD
Testosterone Propionate—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000481	0.00099	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—CCND1—ovarian cancer	0.000479	0.00301	CbGpPWpGaD
Testosterone Propionate—Nervous system disorder—Doxorubicin—ovarian cancer	0.000479	0.000986	CcSEcCtD
Testosterone Propionate—Insomnia—Epirubicin—ovarian cancer	0.000477	0.000983	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—CTNNB1—ovarian cancer	0.000475	0.00298	CbGpPWpGaD
Testosterone Propionate—Skin disorder—Doxorubicin—ovarian cancer	0.000474	0.000977	CcSEcCtD
Testosterone Propionate—Paraesthesia—Epirubicin—ovarian cancer	0.000474	0.000976	CcSEcCtD
Testosterone Propionate—Progesterone—ESR1—ovarian cancer	0.000473	0.0146	CrCbGaD
Testosterone Propionate—Dyspnoea—Epirubicin—ovarian cancer	0.00047	0.000969	CcSEcCtD
Testosterone Propionate—Nausea—Docetaxel—ovarian cancer	0.000465	0.000957	CcSEcCtD
Testosterone Propionate—AR—Androgen receptor signaling pathway—PTEN—ovarian cancer	0.000463	0.00291	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000455	0.000938	CcSEcCtD
Testosterone Propionate—Fatigue—Epirubicin—ovarian cancer	0.000455	0.000937	CcSEcCtD
Testosterone Propionate—Pain—Epirubicin—ovarian cancer	0.000451	0.000929	CcSEcCtD
Testosterone Propionate—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000445	0.000916	CcSEcCtD
Testosterone Propionate—Insomnia—Doxorubicin—ovarian cancer	0.000441	0.00091	CcSEcCtD
Testosterone Propionate—Paraesthesia—Doxorubicin—ovarian cancer	0.000438	0.000903	CcSEcCtD
Testosterone Propionate—Dyspnoea—Doxorubicin—ovarian cancer	0.000435	0.000897	CcSEcCtD
Testosterone Propionate—Feeling abnormal—Epirubicin—ovarian cancer	0.000435	0.000896	CcSEcCtD
Testosterone Propionate—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000431	0.000889	CcSEcCtD
Testosterone Propionate—AR—Generic Transcription Pathway—YAP1—ovarian cancer	0.000428	0.00269	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CDH1—ovarian cancer	0.000421	0.00265	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000421	0.000868	CcSEcCtD
Testosterone Propionate—Fatigue—Doxorubicin—ovarian cancer	0.000421	0.000867	CcSEcCtD
Testosterone Propionate—Urticaria—Epirubicin—ovarian cancer	0.000419	0.000863	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—ovarian cancer	0.000419	0.00263	CbGpPWpGaD
Testosterone Propionate—Pain—Doxorubicin—ovarian cancer	0.000417	0.00086	CcSEcCtD
Testosterone Propionate—Abdominal pain—Epirubicin—ovarian cancer	0.000417	0.000859	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000416	0.00261	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—ovarian cancer	0.000415	0.0026	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—STAT3—ovarian cancer	0.000414	0.0026	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CYTB—ovarian cancer	0.000405	0.00254	CbGpPWpGaD
Testosterone Propionate—Feeling abnormal—Doxorubicin—ovarian cancer	0.000402	0.000829	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	0.000401	0.00252	CbGpPWpGaD
Testosterone Propionate—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000399	0.000822	CcSEcCtD
Testosterone Propionate—AR—Gene Expression—TTF1—ovarian cancer	0.000398	0.0025	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Epirubicin—ovarian cancer	0.000389	0.000801	CcSEcCtD
Testosterone Propionate—CYP17A1—Metabolism—CYTB—ovarian cancer	0.000388	0.00244	CbGpPWpGaD
Testosterone Propionate—Urticaria—Doxorubicin—ovarian cancer	0.000388	0.000799	CcSEcCtD
Testosterone Propionate—Abdominal pain—Doxorubicin—ovarian cancer	0.000386	0.000795	CcSEcCtD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	0.000379	0.00238	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000379	0.00238	CbGpPWpGaD
Testosterone Propionate—Asthenia—Epirubicin—ovarian cancer	0.000378	0.00078	CcSEcCtD
Testosterone Propionate—UGT1A1—Metabolism—NME2—ovarian cancer	0.000377	0.00237	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—EGFR—ovarian cancer	0.000376	0.00236	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—PGR—ovarian cancer	0.000373	0.00235	CbGpPWpGaD
Testosterone Propionate—Pruritus—Epirubicin—ovarian cancer	0.000373	0.000769	CcSEcCtD
Testosterone Propionate—Spironolactone—ABCB1—ovarian cancer	0.000371	0.0115	CrCbGaD
Testosterone Propionate—AR—Gene Expression—NR5A1—ovarian cancer	0.000361	0.00227	CbGpPWpGaD
Testosterone Propionate—Diarrhoea—Epirubicin—ovarian cancer	0.000361	0.000744	CcSEcCtD
Testosterone Propionate—AR—Coregulation of Androgen receptor activity—AKT1—ovarian cancer	0.000361	0.00227	CbGpPWpGaD
Testosterone Propionate—Hypersensitivity—Doxorubicin—ovarian cancer	0.00036	0.000741	CcSEcCtD
Testosterone Propionate—COMT—Metabolism—PPP1CC—ovarian cancer	0.000354	0.00222	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—BRIP1—ovarian cancer	0.000354	0.00222	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—MTOR—ovarian cancer	0.000351	0.0022	CbGpPWpGaD
Testosterone Propionate—Asthenia—Doxorubicin—ovarian cancer	0.00035	0.000722	CcSEcCtD
Testosterone Propionate—Dizziness—Epirubicin—ovarian cancer	0.000349	0.000719	CcSEcCtD
Testosterone Propionate—AR—Generic Transcription Pathway—PARP1—ovarian cancer	0.000347	0.00218	CbGpPWpGaD
Testosterone Propionate—Pruritus—Doxorubicin—ovarian cancer	0.000345	0.000711	CcSEcCtD
Testosterone Propionate—Norethindrone—ABCB1—ovarian cancer	0.000345	0.0107	CrCbGaD
Testosterone Propionate—CYP17A1—Metabolism—PPP1CC—ovarian cancer	0.000339	0.00213	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—BRIP1—ovarian cancer	0.000339	0.00213	CbGpPWpGaD
Testosterone Propionate—Vomiting—Epirubicin—ovarian cancer	0.000335	0.000691	CcSEcCtD
Testosterone Propionate—Diarrhoea—Doxorubicin—ovarian cancer	0.000334	0.000688	CcSEcCtD
Testosterone Propionate—Rash—Epirubicin—ovarian cancer	0.000333	0.000685	CcSEcCtD
Testosterone Propionate—Dermatitis—Epirubicin—ovarian cancer	0.000332	0.000685	CcSEcCtD
Testosterone Propionate—Headache—Epirubicin—ovarian cancer	0.00033	0.000681	CcSEcCtD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.000329	0.00206	CbGpPWpGaD
Testosterone Propionate—Dizziness—Doxorubicin—ovarian cancer	0.000323	0.000665	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CASP3—ovarian cancer	0.000323	0.00203	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—CASP3—ovarian cancer	0.000314	0.00197	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CCND1—ovarian cancer	0.000314	0.00197	CbGpPWpGaD
Testosterone Propionate—Nausea—Epirubicin—ovarian cancer	0.000313	0.000646	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CTNNB1—ovarian cancer	0.000311	0.00195	CbGpPWpGaD
Testosterone Propionate—Vomiting—Doxorubicin—ovarian cancer	0.00031	0.000639	CcSEcCtD
Testosterone Propionate—Rash—Doxorubicin—ovarian cancer	0.000308	0.000634	CcSEcCtD
Testosterone Propionate—Dermatitis—Doxorubicin—ovarian cancer	0.000307	0.000633	CcSEcCtD
Testosterone Propionate—Headache—Doxorubicin—ovarian cancer	0.000306	0.00063	CcSEcCtD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—PTEN—ovarian cancer	0.000303	0.0019	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	0.000303	0.0019	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	0.000295	0.00185	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000292	0.00183	CbGpPWpGaD
Testosterone Propionate—Nausea—Doxorubicin—ovarian cancer	0.00029	0.000597	CcSEcCtD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—ovarian cancer	0.000288	0.00181	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—VEGFA—ovarian cancer	0.000274	0.00172	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	0.000273	0.00171	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	0.000267	0.00168	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.000267	0.00168	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—AKT1—ovarian cancer	0.000267	0.00168	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	0.00026	0.00163	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	0.000258	0.00162	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—MYC—ovarian cancer	0.000252	0.00158	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	0.000251	0.00158	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000247	0.00155	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—MAPK1—ovarian cancer	0.000246	0.00155	CbGpPWpGaD
Testosterone Propionate—Hydrocortisone—ABCB1—ovarian cancer	0.000246	0.00764	CrCbGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—EGFR—ovarian cancer	0.000246	0.00155	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CYTB—ovarian cancer	0.000243	0.00152	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—YAP1—ovarian cancer	0.000237	0.00149	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000234	0.00147	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—KRAS—ovarian cancer	0.000233	0.00146	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—YAP1—ovarian cancer	0.000227	0.00143	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	0.000227	0.00143	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000225	0.00141	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—MAPK1—ovarian cancer	0.000224	0.00141	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	0.000215	0.00135	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—BRIP1—ovarian cancer	0.000212	0.00133	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PPP1CC—ovarian cancer	0.000212	0.00133	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	0.000209	0.00131	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—TP53—ovarian cancer	0.000207	0.0013	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—YAP1—ovarian cancer	0.000206	0.00129	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	0.000204	0.00128	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	0.000204	0.00128	CbGpPWpGaD
Testosterone Propionate—Progesterone—ABCB1—ovarian cancer	0.000201	0.00622	CrCbGaD
Testosterone Propionate—AR—Generic Transcription Pathway—ESR1—ovarian cancer	0.000199	0.00125	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000198	0.00124	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—FASN—ovarian cancer	0.000194	0.00122	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	0.000193	0.00121	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—SLC5A5—ovarian cancer	0.00019	0.0012	CbGpPWpGaD
Testosterone Propionate—Testosterone—ABCB1—ovarian cancer	0.00019	0.00588	CrCbGaD
Testosterone Propionate—CYP17A1—Metabolism—FASN—ovarian cancer	0.000185	0.00116	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—IL6—ovarian cancer	0.000185	0.00116	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—SLC2A1—ovarian cancer	0.000184	0.00116	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—SLC5A5—ovarian cancer	0.000182	0.00115	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—PGR—ovarian cancer	0.00018	0.00113	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—HRAS—ovarian cancer	0.00018	0.00113	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	0.000177	0.00111	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CYP1B1—ovarian cancer	0.000176	0.00111	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—SLC2A1—ovarian cancer	0.000176	0.00111	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—AKT1—ovarian cancer	0.000175	0.0011	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000172	0.00108	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	0.000171	0.00108	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CYP1B1—ovarian cancer	0.000169	0.00106	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—PARP1—ovarian cancer	0.000167	0.00105	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PPP2R1A—ovarian cancer	0.000156	0.000982	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PPP2R1A—ovarian cancer	0.00015	0.00094	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.000149	0.000936	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—ABCB1—ovarian cancer	0.000145	0.000912	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	0.000145	0.000909	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—TYMS—ovarian cancer	0.000143	0.000896	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—YAP1—ovarian cancer	0.000142	0.000893	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—ABCB1—ovarian cancer	0.000139	0.000873	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—TYMS—ovarian cancer	0.000137	0.000858	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—PPP2R1A—ovarian cancer	0.000136	0.000852	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—FASN—ovarian cancer	0.000116	0.000728	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CAV1—ovarian cancer	0.000115	0.000722	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—SLC5A5—ovarian cancer	0.000114	0.000716	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—SLC2A1—ovarian cancer	0.00011	0.000692	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CAV1—ovarian cancer	0.00011	0.000691	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CYP1B1—ovarian cancer	0.000106	0.000663	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	0.000105	0.00066	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PIK3CG—ovarian cancer	0.000105	0.000657	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—MYC—ovarian cancer	0.000104	0.000651	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PIK3CG—ovarian cancer	0.0001	0.000629	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—ESR1—ovarian cancer	9.6e-05	0.000603	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PPP2R1A—ovarian cancer	9.37e-05	0.000588	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PIK3CD—ovarian cancer	9.2e-05	0.000578	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PIK3CD—ovarian cancer	8.81e-05	0.000553	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ABCB1—ovarian cancer	8.7e-05	0.000546	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—TYMS—ovarian cancer	8.54e-05	0.000537	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PIK3CB—ovarian cancer	8.02e-05	0.000504	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PIK3CB—ovarian cancer	7.68e-05	0.000482	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PTEN—ovarian cancer	6.93e-05	0.000435	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CAV1—ovarian cancer	6.88e-05	0.000432	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PTEN—ovarian cancer	6.64e-05	0.000417	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PIK3CG—ovarian cancer	6.27e-05	0.000394	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PIK3CD—ovarian cancer	5.51e-05	0.000346	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—MAPK3—ovarian cancer	5.13e-05	0.000322	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—MYC—ovarian cancer	4.99e-05	0.000314	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PIK3CA—ovarian cancer	4.89e-05	0.000307	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PIK3CB—ovarian cancer	4.8e-05	0.000302	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PIK3CA—ovarian cancer	4.68e-05	0.000294	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PTEN—ovarian cancer	4.15e-05	0.000261	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—AKT1—ovarian cancer	3.99e-05	0.000251	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—AKT1—ovarian cancer	3.82e-05	0.00024	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—AKT1—ovarian cancer	3.46e-05	0.000218	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PIK3CA—ovarian cancer	2.93e-05	0.000184	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—AKT1—ovarian cancer	2.39e-05	0.00015	CbGpPWpGaD
